Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Brunsveld

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Science (New York, N.Y.)|December 31, 1997
Reversible polymers formed from self-complementary monomers using quadruple hydrogen bondingR P Sijbesma, F H Beijer, L Brunsveld, et al.
Alimentary Pharmacology & Therapeutics|December 6, 2017
Switching from infliximab innovator to biosimilar in patients with inflammatory bowel disease: a 12-month multicentre observational prospective cohort studyE M H Schmitz, P J Boekema, J W A Straathof, et al.
Journal of Thrombosis and Haemostasis : JTH|August 22, 2014
Determination of dabigatran, rivaroxaban and apixaban by ultra-performance liquid chromatography - tandem mass spectrometry (UPLC-MS/MS) and coagulation assays for therapy monitoring of novel direct oral anticoagulantsE M H Schmitz, K Boonen, D J A van den Heuvel, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Science (New York, N.Y.)|December 31, 1997
Reversible polymers formed from self-complementary monomers using quadruple hydrogen bondingR P Sijbesma, F H Beijer, L Brunsveld, et al.
Alimentary Pharmacology & Therapeutics|December 6, 2017
Switching from infliximab innovator to biosimilar in patients with inflammatory bowel disease: a 12-month multicentre observational prospective cohort studyE M H Schmitz, P J Boekema, J W A Straathof, et al.
Journal of Thrombosis and Haemostasis : JTH|August 22, 2014
Determination of dabigatran, rivaroxaban and apixaban by ultra-performance liquid chromatography - tandem mass spectrometry (UPLC-MS/MS) and coagulation assays for therapy monitoring of novel direct oral anticoagulantsE M H Schmitz, K Boonen, D J A van den Heuvel, et al.
Pageof 2